Treatment of newly diagnosed, high-grade, malignant glioma with polifeprosan 20 containing carmustine implant (Gliadel wafer) using MR spectroscopy data as a primary indicator of therapeutic response.
Phase of Trial: Phase II
Latest Information Update: 17 Oct 2006
At a glance
- Drugs Carmustine (Primary)
- Indications Glioma
- Focus Therapeutic Use
- 17 Oct 2006 New trial record.